Delivery of curcumin within emulsome nanoparticles enhances the anti-cancer activity in androgen-dependent prostate cancer cell.

Zeynep Busra BolatZeynep IslekFikrettin SahinMehmet Hikmet Ucisik

Published in: Molecular biology reports (2023)

Presented safety and anticancer activity of CurcuEmulsomes on LNCaP cell line highlights the potential of CurcuEmulsomes to benefit intrinsic anticancer activities of curcumin in androgen dependent prostate cancer therapy.

Keyphrases

prostate cancer
cancer therapy
benign prostatic hyperplasia
drug delivery
risk assessment
climate change